New York Times article breaks down barriers to recruitment and brings hope with a new trial

Photo credit: Zack Wittman for The New York Times

The New York Times recently covered a new clinical trial effort Eli Lilly is undertaking, the TRAILBLAZER-ALZ clinical research study. The study, which UCI MIND investigators are participating in, aims to enroll 375 people with early Alzheimer’s disease. To learn more about the TRAILBLAZER-ALZ study, click here, or contact us at research@mind.uci.edu or call 949.824.0008.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.